Clinical trial
An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an…
NCT00343226 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00343226 |
|---|---|
| Title | An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation. |
| Official title | An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation. |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplantation |
| Intervention type | Drug |
| Interventions | Basiliximab |
| Enrollment | 48 |
| Start date | May 1, 2002 |
| Primary completion | Apr 1, 2005 |
| First posted | Jun 22, 2006 |
| Last update posted | Aug 25, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: